```html

Nodular Psoriasis – A Comprehensive Medical Guide

Overview

Nodular psoriasis (also called “hyperkeratotic psoriasis” or “psoriatic nodules”) is a rare, chronic skin disorder characterized by thick, raised, dome‑shaped plaques that may feel firm to the touch. It is considered a variant of plaque psoriasis, the most common form of psoriasis, but it tends to produce larger, more solid‑looking lesions that can be mistaken for other skin conditions such as warts, keratoacanthomas, or even skin cancer.

Although any age can be affected, nodular psoriasis most often appears in adults between 30 and 60 years old. It is slightly more common in males than females (approximately 1.3 : 1). The exact prevalence is uncertain because the condition is under‑reported, but studies suggest it accounts for 2–5 % of all psoriasis cases worldwide [1] CDC, 2023.

Symptoms

The clinical picture can vary, but the hallmark features include:

• Raised, dome‑shaped nodules: Firm, well‑circumscribed plaques that are 0.5–2 cm in diameter, sometimes larger. The surface may be smooth or verrucous (wart‑like).
• Hyperkeratosis: Excessive buildup of keratin leads to thick, scaly surfaces that may be silvery‑white or yellowish.
• Red or pink base: The base of the nodule is usually erythematous, indicating underlying inflammation.
• Itching or burning: Many patients report pruritus, stinging, or a mild burning sensation.
• Painful pressure: Because nodules are firm, they can become tender when pressed or when clothing rubs against them.
• Location: Common sites include elbows, knees, scalp, back, and, less frequently, the face or genital area.
• Koebner phenomenon: New nodules may develop at sites of skin injury (scratches, cuts, pressure).
• Associated psoriasis lesions: Up to 60 % of patients have concurrent classic plaque psoriasis elsewhere on the body.

Rarely, lesions may become ulcerated or secondary infected, especially if scratched.

Causes and Risk Factors

Pathophysiology

Psoriasis is an immune‑mediated disease driven by overactive T‑cells that trigger inflammation and rapid skin cell turnover. In nodular psoriasis, the same inflammatory pathways (primarily the IL‑23/Th17 axis) are active, but there is an additional imbalance that promotes keratinocyte hyperproliferation, leading to the nodular architecture.

Genetic Factors

• Strong family history: First‑degree relatives have a 2–3‑fold increased risk.
• Specific HLA‑Cw6 and PSORS1 loci are linked to early‑onset psoriasis, which can include nodular forms.

Environmental Triggers

• Skin injury (Koebner phenomenon) – cuts, burns, tattoos.
• Stress – acute emotional or physical stress can flare disease.
• Infections – streptococcal throat infection or HIV may precipitate worsening.
• Medications – beta‑blockers, lithium, antimalarials, and interferon‑α can aggravate psoriasis.
• Smoking & alcohol – Both increase severity and complicate treatment.

Who Is at Higher Risk?

• Adults 30–60 y with a personal or family history of psoriasis.
• Individuals with obesity (BMI ≥ 30) – adipose tissue releases pro‑inflammatory cytokines.
• People with other autoimmune diseases (e.g., rheumatoid arthritis, inflammatory bowel disease).
• Patients on immunosuppressive or certain psychiatric medications.

Diagnosis

Diagnosis is primarily clinical, but confirming nodular psoriasis often requires a combination of history, physical examination, and selective testing to rule out mimickers.

Clinical Evaluation

1. History – Onset, distribution, family history, triggers, prior psoriasis treatments.
2. Physical exam – Inspection of lesion morphology, size, and presence of classic plaques elsewhere.

Skin Biopsy

A 4‑mm punch biopsy of an active nodule is the gold‑standard when diagnosis is uncertain. Histopathology typically shows:

• Psoriasiform epidermal hyperplasia (regular acanthosis).
• Parakeratosis with neutrophil aggregates (Munro microabscesses).
• Thickened stratum corneum (hyperkeratosis).
• Dilated, tortuous capillaries in the dermal papillae.

Additional Tests (when indicated)

• Dermatoscopy – Helps differentiate from keratoacanthoma.
• Culture or PCR – If secondary infection is suspected.
• Blood work – CBC, liver function, and fasting lipids for baseline before systemic therapy.

Treatment Options

Therapy is individualized based on disease severity, lesion location, comorbidities, and patient preferences. Goals are to reduce inflammation, flatten nodules, alleviate symptoms, and prevent complications.

Topical Therapies

• High‑potency corticosteroids (e.g., clobetasol propionate 0.05 %): Applied once daily for 2–4 weeks, then tapered.
• Vitamin D analogues (calcipotriene, calcitriol): Useful for milder lesions; may be combined with steroids for synergistic effect.
• Coal tar preparations: Reduce scaling and inflammation; often used in combination with UV therapy.
• Topical retinoids (tazarotene): Helpful for hyperkeratotic plaques but may irritate.

Phototherapy

• NB‑UVB (narrowband ultraviolet B): 3‑5 sessions per week for 12–16 weeks; effective for widespread disease.
• Excimer laser (308 nm): Targets limited areas, useful for stubborn nodules.

Systemic Medications

Indicated for moderate‑to‑severe disease or when topical treatments fail.

• Traditional systemic agents
  • Methotrexate (15–25 mg weekly) – monitor liver enzymes, CBC.
  • Acitretin (25–50 mg daily) – especially helpful for keratotic lesions; contraindicated in pregnancy.
  • Ciclosporin (2–5 mg/kg/day) – rapid control but requires renal monitoring.
• Biologic therapies (target specific immune pathways)
  • TNF‑α inhibitors: Etanercept, adalimumab, infliximab.
  • IL‑12/23 inhibitor: Ustekinumab.
  • IL‑17 inhibitors: Secukinumab, ixekizumab, brodalumab.
  • IL‑23 inhibitors: Guselkumab, risankizumab, tildrakizumab.

  Biologics have transformed outcomes for nodular psoriasis, with >70 % of patients achieving ≥75 % improvement in the Psoriasis Area and Severity Index (PASI‑75) within 12 weeks [2] Mayo Clinic, 2022.

Procedural Options

• Cryotherapy – Liquid nitrogen can flatten solitary nodules but may cause hypopigmentation.
• Laser ablation – CO₂ or Er:YAG laser removes thick hyperkeratotic tissue; often combined with topical therapy.
• Intralesional corticosteroid injection – Triamcinolone acetonide (10‑40 mg/mL) directly into nodules for rapid reduction.

Lifestyle and Adjunctive Measures

• Moisturize daily with thick, fragrance‑free emollients to reduce scaling.
• Avoid triggers: smoking cessation, limit alcohol, stress‑management techniques (mindfulness, exercise).
• Weight management – modest weight loss (5‑10 % of body weight) can improve response to systemic therapy.
• Gentle skin care – use mild, pH‑balanced cleansers; avoid harsh scrubbing.

Living with Nodular Psoriasis

Daily Skin‑Care Routine

1. Morning: Cleanse with lukewarm water and a mild soap, apply a barrier‑repair cream (e.g., ceramide‑containing) while skin is still damp.
2. Medication: Follow prescribed topical schedule; allow medications to absorb before dressing.
3. Evening: Re‑apply moisturizer; consider a short (10‑15 min) warm compress on particularly thick nodules before bedtime to soften scales.

Clothing & Lifestyle Tips

• Wear soft, breathable fabrics (cotton, bamboo) to reduce friction.
• Avoid tight sleeves, belts, or jewelry that can irritate nodules.
• Use protective padding (e.g., silicone sleeves) during sports or manual labor.

Psychosocial Support

Visible skin lesions can affect self‑esteem. Counseling, support groups, or patient‑advocacy organizations (National Psoriasis Foundation) are valuable resources.

Monitoring & Follow‑up

Schedule dermatology visits every 3–6 months while on systemic/biologic therapy. Keep a symptom diary noting flare triggers, medication side effects, and any new lesions.

Prevention

While genetics cannot be changed, the following strategies can lower the risk of developing nodular psoriasis or reduce flare frequency:

• Maintain a healthy weight – BMI < 25 is associated with milder disease.
• Quit smoking – Smoking increases psoriasis risk by up to 70 % [3] WHO, 2021.
• Limit alcohol – More than 2 drinks per day correlates with increased severity.
• Manage stress – Regular exercise, yoga, or meditation.
• Protect skin from trauma – Use protective gear when gardening, playing sports, or working with tools.
• Adhere to treatment – Early, consistent therapy can prevent evolution to nodular forms.

Complications

If left unchecked, nodular psoriasis can lead to several medical and quality‑of‑life issues:

• Secondary bacterial infection – Staphylococcus aureus or Streptococcus can colonize cracked nodules, requiring antibiotics.
• Psoriatic arthritis – Up to 30 % of psoriasis patients develop joint involvement; nodular disease does not provide protection.
• Psychological distress – Depression, anxiety, and social isolation are common.
• Scarring or pigment changes – Persistent lesions may lead to atrophic scars or post‑inflammatory hyper/hypopigmentation.
• Reduced mobility – Large nodules over joints can limit range of motion.

When to Seek Emergency Care

---

Sources:
[1] Centers for Disease Control and Prevention. “Psoriasis Fact Sheet.” 2023.
[2] Mayo Clinic. “Biologic Therapy for Psoriasis: Effectiveness & Safety.” 2022.
[3] World Health Organization. “Smoking and Skin Disease.” 2021.
Additional references include National Psoriasis Foundation, American Academy of Dermatology, and peer‑reviewed articles from Journal of the American Academy of Dermatology and Nature Reviews Dermatology.

```